Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)
Clinical trial NCT03977155 · COMPLETED
Trial details
- NCT number
- NCT03977155
- Sponsor
- Boston Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-04
- Primary completion
- 2020-05-06
- Enrollment
- 133
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.